Strata Critical Medical, Inc. Class A Common Stock (SRTA) is a publicly traded the market company. As of September 8, 2026, SRTA trades at $5.31 with a market cap of $470.64M and a P/E ratio of 10.54. SRTA moved -0.19% today. Year to date, SRTA is +10.39%; over the trailing twelve months it is +32.75%. Its 52-week range spans $3.85 to $6.50. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces SRTA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Strata Critical Medical, Inc. Class A Common Stock (SRTA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SRTA moved -0.19% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $5.31 |
| Market Cap | $470.64M |
| P/E Ratio | 10.54 |
| EPS | $0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.50 |
| 52-Week Low | $3.85 |
| Volume | 788.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $197.14M |
| Net Income | $41.35M |
| Gross Margin | 20.86% |
2 analysts cover SRTA: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.